Improved patient outcomes and experience, shorter length of stay and cost effectiveness drive the recognition of value in today’s rapidly-evolving and competitive healthcare environment.
Stago contracted with Alira Health to conduct an economic evaluation comparing the use of the STA-Liatest D-Di assay to other D-dimer assays in conjunction with a probability assessment model for exclusion of VTE.
The economic evaluation was performed according to the definition of Health Care Economic Information (HCEI) as defined in section 502(a), as amended by section 114 of FDAMA and section 3037 of the 21st Century Cures Act.
For more information, a white paper is now available.
Don’t hesitate to contact your local interlocutor to have it.